Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

Clinical trial NCT06844487 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06844487
Sponsor: Jean-Pierre Van geertruyden
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Mpox (Monkeypox)Vaccination Immunogenicity Safety Infants Children

Start date: 2025-05-29
Primary completion: 2026-06-30
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.